Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T13:42:02.712Z.
Calculation as of: 2026-10-06T13:42:02.712Z.
Quote observation: 2026-10-06T13:40:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0892caefd8f82b9b6348fc9a5fa5a469bdb14ad1115ffcc50d65bebd568510ae
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2024-11-12.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Journey Medical Corporation
Market Cap
$183.71M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$178.54M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$193.74M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$173.34M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$169.95M
EV/EBIT Ratio
N/A
TTM Avg
8.53x
3Y Avg
141.14x
5Y Avg
141.14x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Journey Medical Corporation (DERM) | $183.71M | N/A | N/A | N/A | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $178.54M | N/A | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $177.29M | N/A | N/A | N/A | N/A |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $193.74M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $173.34M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $194.49M | N/A | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $171.61M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $169.95M | N/A | 8.53x | 141.14x | 141.14x |
| Electra Therapeutics Inc. (ETRA)vs › | $203.00M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $161.12M | N/A | 189.93x | 95.49x | 94.46x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2024-11-12 | 50.78x |
| 2024-11-11 | 52.01x |
| 2024-11-08 | 52.66x |
| 2024-11-07 | 53.23x |
| 2024-11-06 | 50.69x |
| 2024-11-05 | 49.18x |
| 2024-11-04 | 49.56x |
| 2024-11-01 | 57.56x |
| 2024-10-31 | 53.61x |
| 2024-10-30 | 53.42x |
| 2024-10-29 | 53.51x |
| 2024-10-28 | 55.96x |
| 2024-10-25 | 53.70x |
| 2024-10-24 | 50.50x |
| 2024-10-23 | 55.49x |
| 2024-10-22 | 57.37x |
| 2024-10-21 | 58.97x |
| 2024-10-18 | 57.09x |
| 2024-10-17 | 55.68x |
| 2024-10-16 | 58.60x |
| 2024-10-15 | 53.70x |
| 2024-10-14 | 54.45x |
| 2024-10-11 | 54.36x |
| 2024-10-10 | 55.96x |
| 2024-10-09 | 55.49x |
| 2024-10-08 | 56.90x |
| 2024-10-07 | 58.69x |
| 2024-10-04 | 60.95x |
| 2024-10-03 | 58.69x |
| 2024-10-02 | 58.50x |
| 2024-10-01 | 54.17x |
| 2024-09-30 | 52.66x |
| 2024-09-27 | 53.32x |
| 2024-09-26 | 50.97x |
| 2024-09-25 | 50.50x |
| 2024-09-24 | 48.43x |
| 2024-09-23 | 48.05x |
| 2024-09-20 | 47.02x |
| 2024-09-19 | 47.30x |
| 2024-09-18 | 47.68x |
| 2024-09-17 | 47.02x |
| 2024-09-16 | 50.59x |
| 2024-09-13 | 48.05x |
| 2024-09-12 | 46.64x |
| 2024-09-11 | 44.57x |
| 2024-09-10 | 44.29x |
| 2024-09-09 | 44.95x |
| 2024-09-06 | 43.53x |
| 2024-09-05 | 43.72x |
| 2024-09-04 | 44.38x |
| 2024-09-03 | 44.57x |
| 2024-08-30 | 46.36x |
| 2024-08-29 | 48.52x |
| 2024-08-28 | 47.96x |
| 2024-08-27 | 49.28x |
| 2024-08-26 | 45.23x |
| 2024-08-23 | 44.95x |
| 2024-08-22 | 41.93x |
| 2024-08-21 | 40.90x |
| 2024-08-20 | 41.37x |
| 2024-08-19 | 42.50x |
| 2024-08-16 | 41.18x |
| 2024-08-15 | 42.40x |
| 2024-08-14 | 44.29x |
| 2024-08-13 | 44.85x |
